Home / Program / Main Program / Symposium 21
Symposium 21:Smoking and tuberculosis: a dangerous combination

Tobacco smoke has a profound impact on airway inflammation and is well-documented to be strong risk factor for COPD and lung cancer. Meanwhile, tobacco smoke also impair the immunity of alveolar macrophages and lymphocytes, which may lead to increased risk of pulmonary infection, including pulmonary tuberculosis (PTB).
Tobacco smokers are two to three times more likely to develop PTB compared to non-smokers. Smokers who have TB have a much harder time recovering from the disease and are more likely to experience relapses and impairment of lung function or pulmonary sequalae.
The interaction between tobacco smoke and TB is a complex one, with tobacco smoking increasing the risk of developing TB and compromised the treatment outcomes. The aim of this symposium is to elaborate the impact of smoke on lung immunity and it association with risk of PTB.

Date: Sunday, April 28, 2023 | Time: 15:00-16:30 (GMT+8)
Topic Speaker Country / Region
15:00-15:30 Impact of cigarette smoke on lung health: inflammation and immunity TBD TBD
15:30-16:00 Smoking cessation: the experiences in Hong Kong Dr. Chi Chiu Leung Hong Kong
16:00-16:30 Impact of cigarette smoke on lung health: interaction between smoke and tuberculosis Dr. Sheng-Wei Pan Taiwan